Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Promotes Preventive Care, Wellness In US Health Debate

Jan 26 2017

• By Eileen Francis

Related Content

Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012

Apr 25 2011

Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

Jan 25 2017

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

Jan 26 2017

J&J Outlines Pricing Transparency Plan, Will Others Follow?

Jan 26 2017

FDA Scorches Sunscreen Wipe Marketers With October Warning Letters

Oct 25 2016

OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House

Nov 11 2016

Related Companies

Johnson & Johnson

Additional Topics

United States Elections Dietary Supplements Sales & Earnings OTC Drugs Consumer

More from Elections

More from Legislation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window